Punchline: From a single breakthrough to a scalable platform, GLP-1s have redefined Lillys business, positioning the company at the center of a new metabolic category.
GLP-1s absolutely have their place and work for the right people
These drugs are very effective at treating obesity and diabetes, and also reduce risk of heart disease and progression of kidney disease
By combining diagnostics, medication when appropriate, and proven behavior change, we help your body work better from the inside out. Nooms Chief Medical Officer FAQ Read more about weight-loss medications Our clinical team offers a wide array of medications to give the best treatment to those who qualify.
The risk is not eating enough protein, which leads to muscle loss alongside fat loss a bad outcome
This interview has been edited and condensed for clarity .